181 related articles for article (PubMed ID: 9717684)
1. State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis.
Hoppe JE
Infection; 1998; 26(4):242-6. PubMed ID: 9717684
[No Abstract] [Full Text] [Related]
2. Whooping cough--aspects of pathogenesis and treatment.
Trollfors B
Acta Otolaryngol Suppl; 1984; 407():33-9. PubMed ID: 6093425
[No Abstract] [Full Text] [Related]
3. In vitro activity of macrolides against Bordetella pertussis strains isolated in 1968 and 30 years later in Poland.
Chodorowska M; Tyski S; Kuklińska D
Clin Microbiol Infect; 2000 Jan; 6(1):50-2. PubMed ID: 11168039
[No Abstract] [Full Text] [Related]
4. Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis.
Lewis K; Saubolle MA; Tenover FC; Rudinsky MF; Barbour SD; Cherry JD
Pediatr Infect Dis J; 1995 May; 14(5):388-91. PubMed ID: 7638015
[No Abstract] [Full Text] [Related]
5. Whooping Cough in Adults: A Series of Severe Cases.
Zycinska K; Cieplak M; Chmielewska M; Nitsch-Osuch A; Klaczkow A; Hadzik-Blaszczyk M; Kur Z; Wardyn KA
Adv Exp Med Biol; 2017; 955():47-50. PubMed ID: 28039663
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of antimicrobial resistance in contemporary clinical isolates of Bordetella pertussis in Ontario, Canada.
Marchand-Austin A; Memari N; Patel SN; Tang P; Deeks SL; Jamieson FB; Crowcroft NS; Farrell DJ
Int J Antimicrob Agents; 2014 Jul; 44(1):82-4. PubMed ID: 24837412
[No Abstract] [Full Text] [Related]
7. Antimicrobial susceptibility of Bordetella pertussis isolates in the state of Washington.
Galanakis E; Englund JA; Abe P; Qin X
Int J Antimicrob Agents; 2007 May; 29(5):609-11. PubMed ID: 17344029
[No Abstract] [Full Text] [Related]
8. Pharmacotherapy for Bordetella pertussis infection. I. A synthesis of laboratory sciences.
Cimolai N
Int J Antimicrob Agents; 2021 Mar; 57(3):106258. PubMed ID: 33310116
[TBL] [Abstract][Full Text] [Related]
9. Azithromycin Clears
Borkner L; Misiak A; Wilk MM; Mills KHG
Front Immunol; 2018; 9():1764. PubMed ID: 30105030
[TBL] [Abstract][Full Text] [Related]
10. Modifying antibiotic treatment strategies in the face of pertussis surge associated to erythromycin resistance in China.
Shi W; Meng Q; Hu Y; Yao K
J Infect; 2024 Jun; 88(6):106174. PubMed ID: 38719109
[No Abstract] [Full Text] [Related]
11. Antimicrobial Susceptibility and Molecular Detection of Pertactin-producing and Pertactin-Deficient Bordetella pertussis.
Souder E; Vodzak J; Evangelista AT; Long SS
Pediatr Infect Dis J; 2017 Jan; 36(1):119-121. PubMed ID: 27956730
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility testing of Bordetella pertussis in Taiwan prompted by a case of pertussis in a paediatric patient.
Yao SM; Liaw GJ; Chen YY; Yen MH; Chen YH; Mu JJ; Chiang CS
J Med Microbiol; 2008 Dec; 57(Pt 12):1577-1580. PubMed ID: 19018032
[TBL] [Abstract][Full Text] [Related]
13. Crucial role of antibodies to pertactin in Bordetella pertussis immunity.
Hellwig SM; Rodriguez ME; Berbers GA; van de Winkel JG; Mooi FR
J Infect Dis; 2003 Sep; 188(5):738-42. PubMed ID: 12934190
[TBL] [Abstract][Full Text] [Related]
14. Where macrolide resistance is prevalent.
Li Y; Liu X; Zhang B; He Q; Wang Z
APMIS; 2015 Apr; 123(4):361-3. PubMed ID: 25703275
[No Abstract] [Full Text] [Related]
15. In vitro activity and clinical efficacy of macrolides, cefoperazone-sulbactam and piperacillin/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates: A single-centre study in Zhejiang Province, China.
Hua CZ; Wang HJ; Zhang Z; Tao XF; Li JP; Mi YM; Tang LF; Chen ZM
J Glob Antimicrob Resist; 2019 Sep; 18():47-51. PubMed ID: 30710647
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy for Bordetella pertussis infection. II. A synthesis of clinical sciences.
Cimolai N
Int J Antimicrob Agents; 2021 Mar; 57(3):106257. PubMed ID: 33310117
[TBL] [Abstract][Full Text] [Related]
17. The First Report of Macrolide-Resistant Bordetella pertussis Isolation in Japan.
Yamaguchi T; Kawasaki Y; Katsukawa C; Kawahara R; Kawatsu K
Jpn J Infect Dis; 2020 Sep; 73(5):361-362. PubMed ID: 32350216
[TBL] [Abstract][Full Text] [Related]
18. Challenges and prospects in treating macrolide-resistant Bordetella pertussis in Chinese paediatric practice.
Yang R; Xu H; Zhang Z; Liu Q; Wu X
J Infect; 2024 Jul; 89(1):106185. PubMed ID: 38763390
[No Abstract] [Full Text] [Related]
19. [Laboratory diagnosis of pertussis. Role of serology].
Sanz Moreno JC; De Ory Manchón F; González Alonso J; de La Torre JL; Salmerón F; Limia A; Tello O; Pachón I; Amela C; Vázquez J; de Ory F; Sanz JC;
Enferm Infecc Microbiol Clin; 2002 May; 20(5):212-8. PubMed ID: 12006259
[TBL] [Abstract][Full Text] [Related]
20. [Search for antibodies against Bordetella parapertussis in patients with positive culture].
García Ramos E; Giono S; Rivas S
Rev Invest Salud Publica; 1977; 37(1):47-52. PubMed ID: 208129
[No Abstract] [Full Text] [Related]
[Next] [New Search]
